Erastus Muniu
Kenya Medical Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Erastus Muniu.
Parasites & Vectors | 2011
Sammy M. Njenga; Charles Mwandawiro; Erastus Muniu; Mariam T Mwanje; Fatma M Haji; Moses J. Bockarie
BackgroundNeglected tropical diseases (NTDs) are major public health problems in developing countries where they contribute to suffering of populations living in poor settings. As part of a research project started in September 2009 in Kwale district, Coast Region, Kenya, a baseline cross-sectional survey was conducted in 5 rural villages to provide information on the status of NTDs, including urinary schistosomiasis, soil-transmitted helminthiasis (STH), and lymphatic filariasis. This paper presents the results of a parasitological investigation among adults in the study villages.MethodsA total of 599 adults in the 5 study villages were tested for NTD infections in urine, stool and blood. The presence of Schistosoma haematobium infection was determined by the urine filtration method. The presence of STH in stool was determined by Kato-Katz method while filarial antigenaemia was determined using immunochromatographic (ICT) test.ResultsThe study revealed high prevalence of hookworm (41.7%) and schistosomiasis (18.2%) infections among adults in the study villages. Of the 599 individuals examined, 50.1% had one or more helminthic infections. There was low level of polyparasitism with helminthic NTDs in the study population with 9.5% and 1.7% of the participants having two and three infections, respectively.ConclusionsIn the current study, hookworm and schistosomiasis infections were identified as important infections among adults living in areas of high endemicity for these infections. Thus, if this section of the population is left untreated it may remain an important potential reservoir and a source of re-infection for school-age children treated in school deworming programmes. Therefore, there is a need to design novel strategies for preventive chemotherapy interventions that could allow inclusion of adults in an effort to reduce force of infection in high endemic communities.
European Journal of Clinical Nutrition | 2010
Anne S. W. Mburu; D I Thurnham; David Mwaniki; Erastus Muniu; Fred Alumasa
Background/Objectives:Plasma zinc is an important biomarker of zinc status, but the concentration is depressed by inflammation.Subjects/Methods:Apparently healthy adults, who tested positive twice for human immunodeficiency virus (HIV) but who had not reached stage IV or clinical AIDS, were randomly allocated to receive a food supplement (n=17 and 21) or the food plus a micronutrient capsule (MN; n=10 men and n=33 women) containing 15 mg zinc/day. We used the inflammation biomarkers, C-reactive protein (CRP) and α1-acid glycoprotein (AGP), to identify subjects with and without inflammation and determine the effect of inflammation on the response of plasma zinc concentrations to the MN and food supplements.Results:There were no differences between men and women either in plasma zinc or in the responses to the supplements and their data were combined. Plasma zinc was lower in those with inflammation than without. Repeated measures analysis of variance (ANOVA) showed that inflammation blocked increases in plasma zinc, and there was an approximate 10% increase in plasma zinc concentration in response to the MN supplement (P=0.023) in those without inflammation. Subgroup analysis showed mean changes in plasma zinc of 0.95 and −0.83 μmol/l (P=0.031) in response to the MN and food treatments, respectively, in those without inflammation at both time points.Conclusions:Inflammation seems to block any increase in plasma zinc after MN supplement and it is important to identify those without inflammation to determine the effectiveness of a zinc supplementation program.
Food and Nutrition Bulletin | 2011
Philip Ndemwa; Christine L. Klotz; David Mwaniki; Kai Sun; Erastus Muniu; Pauline Andango; Joyce Owigar; Jee Hyun Rah; Klaus Kraemer; Paul Spiegel; M. W. Bloem; Saskia de Pee; Richard D. Semba
Background Micronutrient powder is a potential strategy to improve iron status and reduce anemia in refugee populations. Objective To evaluate the effect of the availability of home fortification with a micronutrient powder containing 2.5 mg of sodium iron ethylenediaminetetraacetate (NaFeEDTA) on iron status and hemoglobin in women and children in the Kakuma Refugee Camp in northwest Kenya. Methods Hemoglobin and soluble transferrin receptor were measured in 410 children 6 to 59 months of age and 458 women of childbearing age at baseline (just before micronutrient powder was distributed, along with the regular food ration) and at midline (6 months) and endline (13 months) follow-up visits. Results At the baseline, midline, and endline visits, respectively, the mean (± SE) hemoglobin concentration in women was 121.4 ± 0.8, 120.8 ± 0.9, and 120.6 ± 1.0 g/L (p = .42); the prevalence of anemia (hemoglobin < 120 g/L) was 42.6%, 41.3%, and 41.7% (p = .92); and the mean soluble transferrin receptor concentration was 24.1 ± 0.5, 20.7 ± 0.7, and 20.8 ± 0.7 nmol/L (p = .0006). In children, the mean hemoglobin concentration was 105.7 ± 0.6, 109.0 ± 1.5, and 105.5 ± 0.3 g/L (p = .95), respectively; the prevalence of anemia (hemoglobin < 110 g/L) was 55.5%, 52.3%, and 59.8% (p = .26); and the mean soluble transferrin receptor concentration was 36.1 ± 0.7, 29.5 ± 1.9, and 28.4 ± 3.2 nmol/L (p = .02), in models that were adjusted for age using least squares means regression. Conclusions In children and in women of childbearing age, the availability of micronutrient powder was associated with a small improvement in iron status but no significant change in hemoglobin in this refugee camp setting.
Cerebrovascular Diseases Extra | 2018
Lydia Kaduka; Erastus Muniu; Chrispine Owuor Oduor; Jane Mbui; Robai Gakunga; Judith Kwasa; Sylvanus Wabwire; Nathan Okerosi; Anne Korir; Scot C. Remick
Background: Despite the increasing global burden of stroke, there are limited data on stroke from Kenya to guide in decision-making. Stroke occurrence in sub-Saharan Africa has been associated with poor health outcomes. This study sought to establish the stroke incidence density and mortality in Kenya’s leading public tertiary hospitals for purposes of informing clinical practice and policy. Methods: This is a prospective study conducted at Kenya’s leading referral hospitals, namely, Kenyatta National Hospital (KNH) and Moi Teaching and Referral Hospital (MTRH). Adult patients with confirmed cases of stroke were recruited from February 2015 to January 2016 and followed up for a minimum period of 1 year. The WHO 2006 Stroke STEPS instrument was used to collect data on incidence and mortality at days 10 and 28 and every 3 months for 24 months. The person-time of follow-up was computed from admission to death, loss to follow-up, or the end of the study. A survival regression analysis was done using the Cox proportional hazards model. Results: A total of 719 patients were recruited (KNH: n = 406 [56.5%]; MTRH: n = 313 [43.5%]). The mean age was 58.6 ± 18.7 years, and the male-to-female ratio was 1: 1.4. Ischemic stroke accounted for 56.1% of the stroke cases. The peak age for stroke was between 50 and 69 years, when 36.3% of the cases occurred. Mortality at day 10 and day 28 was 18.4 and 26.7%, respectively. The inpatient mortality rate was 21.6%. The stroke incidence density was 507 deaths per 1,000 person-years of follow-up. The mean survival time was significantly different between inpatients (13.9 months; 95% CI: 13.0–14.7) and outpatients (18.6 months; 95% CI: 17.2–19.9) (p < 0.001). A 1-year increase in age increased the hazard by 1.8%. Inpatients had a 3.9-fold increase in hazard compared to outpatients. Conclusions: Mortality due to stroke is high, with poor survival observed in the first year after stroke. The risk of death increases with increasing age and duration of hospital stay. There is need for attention to quality of care and long-term needs of stroke patients to mitigate the high mortality rates observed. Public health initiatives aimed at early screening and diagnosis should be enhanced. Further research is recommended to establish the true burden of stroke at the community level to inform appropriate mitigation measures.
British Journal of Nutrition | 2008
David I. Thurnham; Anne S. W. Mburu; David Mwaniki; Erastus Muniu; Fred Alumasa; Arjan de Wagt
Journal of Nutrition | 2008
Anne S. W. Mburu; David I. Thurnham; David Mwaniki; Erastus Muniu; Fred Alumasa; Arjan de Wagt
African Journal of Health Sciences | 2004
Erick Nordberg; Isaac K. Mwobobia; Erastus Muniu
Cardiovascular Journal of Africa | 2018
Lydia Kaduka; Anne Korir; Chrispine Owuor Oduor; Judith Kwasa; Jane Mbui; Sylvanos Wabwire; Robai Gakunga; Nathan Okerosi; Yvonne Opanga; Isaac Kisiang’ani; Mercy Rotich Chepkurui; Erastus Muniu; Scot C. Remick
BMC Research Notes | 2018
Joseph Mbugua Kabogo; Erastus Muniu; Fred Wamunyokoli; Rachel N. Musoke; Elijah M. Songok
Africa Health Agenda International Journal | 2018
Yvonne Opanga; Lydia Kaduka; Erastus Muniu; Zipporah N. Bukania; Richard Mutisya; Ann Korir; Veronica Thuita; Catherine Nyongesa; Moses Mwangi; Charles Mbakaya